Mylan says it has sufficient
supplies of its EpiPen auto-injector
to meet any anticipated demand
for the product, in the light of
the nationwide US withdrawal of
Sanofi’s Auvi-Q (PD yesterday).
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 04 Nov 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Nov 15
